17 results
8-K
EX-99.1
ITRM
Iterum Therapeutics Plc
29 Mar 24
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
7:15am
and development (R&D) expenses for the fourth quarter and full year 2023 were $9.7 million and $40.0 million, respectively, compared to $5.8 million … and development tax credit. The increase in R&D expenses for the full year was primarily due to the REASSURE trial, partially offset by a decrease in share-based
8-K
EX-99.1
ITRM
Iterum Therapeutics Plc
14 Nov 23
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
12:00am
13.1 million ordinary shares outstanding.
Research and development (R&D) expenses for the third quarter 2023 were $14.9 million, compared to $4.4
8-K
EX-99.1
ITRM
Iterum Therapeutics Plc
11 Aug 23
Iterum Therapeutics Reports Second Quarter 2023 Financial Results
7:15am
had approximately 13.0 million ordinary shares outstanding.
Research and development (R&D) expenses for the second quarter 2023 were $9.0 million
8-K
EX-99.1
ITRM
Iterum Therapeutics Plc
12 May 23
Iterum Therapeutics Reports First Quarter 2023 Financial Results
12:00am
. As of April 30, 2023, we had approximately 12.9 million ordinary shares outstanding.
Research and development (R&D) expenses for the first quarter
8-K
EX-99.1
ITRM
Iterum Therapeutics Plc
10 Nov 22
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
7:15am
approximately 12.2 million ordinary shares outstanding.
Research and development (“R&D”) expenses for the third quarter of 2022 were $4.4 million
8-K
EX-99.1
bss85wv59evj la
12 Aug 22
Iterum Therapeutics Reports Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
2xu0y3uug
13 May 22
Iterum Therapeutics Reports First Quarter 2022 Financial Results
7:16am
8-K
EX-99.1
87bxp8
28 Mar 22
Iterum Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
7:15am
8-K
EX-99.1
gsx2t 9b0ju
12 Mar 21
Iterum Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
7:15am
8-K
EX-99.1
1tpuxnx
16 Nov 20
Iterum Therapeutics Reports Third Quarter 2020 Financial Results
7:00am
8-K
EX-99.1
2fti1y5 iugt9odytwj
6 Aug 20
Iterum Therapeutics Reports Second Quarter 2020 Financial Results
7:00am
8-K
EX-99.1
er9bo2o4gu e9l3
14 May 20
Iterum Therapeutics Reports First Quarter 2020 Financial Results
7:00am
8-K
EX-99.1
urp4h6o6vezz8fkd
12 Mar 20
Iterum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
7:00am
8-K
EX-99.1
6yovsa8l1uemos5ejs
14 Aug 19
Iterum Therapeutics Reports Second Quarter 2019 Financial Results
12:00am
8-K
EX-99.1
ez8f0qcn 96t4na
14 May 19
Iterum Therapeutics Reports First Quarter 2019 Financial Results
7:15am
8-K
EX-99.1
2zca1 m9b1rk
25 Mar 19
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
7:16am
8-K
EX-99.1
e1ektj781xad1mr hm49
14 Nov 18
Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights
7:31am
- Prev
- 1
- Next